Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-22-015510
Filing Date
2022-08-08
Accepted
2022-08-08 16:06:41
Documents
5
Effectiveness Date
2022-08-08

Document Format Files

Seq Description Document Type Size
1 S-8 crsp_2022_s-8_july_2022.htm S-8 174415
2 EX-5.1 crsp-ex5_1.htm EX-5.1 72552
3 EX-23.1 crsp-ex23_1.htm EX-23.1 4719
4 EX-FILING FEES crsp-exfiling_fees.htm EX-FILING FEES 49395
5 GRAPHIC img33470342_0.jpg GRAPHIC 20639
  Complete submission text file 0000950170-22-015510.txt   330628
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266636 | Film No.: 221144343
SIC: 2836 Biological Products, (No Diagnostic Substances)